急性人类免疫缺陷病毒患者中比克替拉韦诱导的伴有嗜酸性粒细胞增多和全身症状的药物反应
Bictegravir-Induced Drug Reaction With Eosinophilia and Systemic Symptoms in a Patient With Acute Human Immunodeficiency Virus.
作者信息
DiLorenzo Madeline A, Medrano Nicola, Chen Jason N, Bawany Fatima, Tran Duy C, Taunk Pulkit, Meehan Shane A, Pomeranz Miriam Keltz, Mgbako Ofole
机构信息
Division of Infectious Diseases and Immunology, Department of Medicine, NYU Langone Health, New York, New York, USA.
Department of Internal Medicine, NYU Langone Health, New York, New York, USA.
出版信息
Open Forum Infect Dis. 2023 Feb 8;10(3):ofad066. doi: 10.1093/ofid/ofad066. eCollection 2023 Mar.
Although drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with antiretrovirals, there are no published reports of bictegravir-induced DRESS. Bictegravir is recommended as first-line treatment for patients with human immunodeficiency virus (HIV). Recognition of DRESS, its skin manifestations, and potential complications is vital for appropriate care and management of acute HIV.
虽然伴有嗜酸性粒细胞增多和全身症状的药物反应（DRESS）与抗逆转录病毒药物有关，但尚无关于比克替拉韦诱发DRESS的报道。比克替拉韦被推荐作为人类免疫缺陷病毒（HIV）患者的一线治疗药物。认识DRESS及其皮肤表现和潜在并发症对于急性HIV的恰当护理和管理至关重要。
Zotero 插件